MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

Q: What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in Q2 2020?

124 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 558868105

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 22,822,754
Total 13F shares: 11,257,505
Share change: -6,005
Total reported value: $1,274,820,026
Put/Call ratio: 55%
Reported price per share: $113.25
Number of holders: 124
Value change: +$4,793,161
Number of buys: 70
Number of sells: 44

Security key

558868105

Report period

Q2 2020

Institutions

124

Top holders

MDGL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2020 Previous quarter: Q1 2020 MADRIGAL PHARMACEUTICALS, INC. SEC filings MADRIGAL PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 558868105

Newer quarter: Q3 2020 Previous quarter: Q1 2020

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Capital Research Global I...

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2020

13F Lead comparable stake: 7.4% Showing 1-6 of 15 holder rows.

Rank 1 holder

Capital Research Global Investors

13F

Ownership: 7.4%
Position: $113.3M

13F

Rank 2 holder

BAKER BROS. ADVISORS LP

13F

Ownership: 6.6%
Position: $100.09M

13F

Rank 3 holder

HealthCor Management, L.P.

13F

Ownership: 6.1%
Position: $93.61M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	7.4%	$113,300,000 1,697,119 shares	—	31 Mar 2020
BAKER BROS. ADVISORS LP	13F Company 13F	6.6%	$100,087,000 1,499,212 shares	—	31 Mar 2020
HealthCor Management, L.P.	13F Company 13F	6.1%	$93,614,000 1,402,250 shares	—	31 Mar 2020
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	3.8%	$58,343,000 873,915 shares	—	31 Mar 2020
VANGUARD GROUP INC	13F Company 13F	3.7%	$55,725,000 834,701 shares	—	31 Mar 2020
BlackRock Finance, Inc.	13F Company 13F	2.8%	$42,018,000 629,402 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

124

11,257,505

Rows available

124

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

106

Q2 2020 holders

124

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend